Kay Seden

Summary

Affiliation: University of Liverpool
Country: UK

Publications

  1. doi request reprint Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospitals Trust, Liverpool, UK
    J Antimicrob Chemother 64:5-8. 2009
  2. doi request reprint New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospitals Trust, and Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
    J Antimicrob Chemother 65:1079-85. 2010
  3. doi request reprint Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Curr Opin HIV AIDS 6:514-26. 2011
  4. doi request reprint Prediction of drug-drug interactions between various antidepressants and efavirenz or boosted protease inhibitors using a physiologically based pharmacokinetic modelling approach
    Marco Siccardi
    Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, 70 Pembroke Place, Liverpool, L69 3GF, UK
    Clin Pharmacokinet 52:583-92. 2013
  5. doi request reprint Global patient safety and antiretroviral drug-drug interactions in the resource-limited setting
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    J Antimicrob Chemother 68:1-3. 2013
  6. doi request reprint Grapefruit-drug interactions
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Drugs 70:2373-407. 2010

Detail Information

Publications6

  1. doi request reprint Antiretroviral drug interactions: often unrecognized, frequently unavoidable, sometimes unmanageable
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospitals Trust, Liverpool, UK
    J Antimicrob Chemother 64:5-8. 2009
    ....
  2. doi request reprint New directly acting antivirals for hepatitis C: potential for interaction with antiretrovirals
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospitals Trust, and Department of Pharmacology and Therapeutics, University of Liverpool, Liverpool, UK
    J Antimicrob Chemother 65:1079-85. 2010
    ..Therapeutic drug monitoring is likely to play a role in the clinical management of such interactions...
  3. doi request reprint Directly acting antivirals for hepatitis C and antiretrovirals: potential for drug-drug interactions
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Curr Opin HIV AIDS 6:514-26. 2011
    ..Potential for DDIs with the DAAs in clinical development and the mechanisms of interaction are also discussed...
  4. doi request reprint Prediction of drug-drug interactions between various antidepressants and efavirenz or boosted protease inhibitors using a physiologically based pharmacokinetic modelling approach
    Marco Siccardi
    Department of Molecular and Clinical Pharmacology, Institute of Translational Medicine, University of Liverpool, 70 Pembroke Place, Liverpool, L69 3GF, UK
    Clin Pharmacokinet 52:583-92. 2013
    ....
  5. doi request reprint Global patient safety and antiretroviral drug-drug interactions in the resource-limited setting
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    J Antimicrob Chemother 68:1-3. 2013
    ....
  6. doi request reprint Grapefruit-drug interactions
    Kay Seden
    NIHR Biomedical Research Centre, Royal Liverpool and Broadgreen University Hospital Trust, Liverpool, UK
    Drugs 70:2373-407. 2010
    ..The aim of this review is to outline the mechanisms of grapefruit-drug interactions and present a comprehensive summary of those agents affected and whether they are likely to be of clinical relevance...